This approach was recently tested by treating IB3.1 cells (a cystic fibrosis cell model harboring the W1282X stop mutation) with caffeine to increase levels of nonsense CFTR-mRNA to restore a functional protein produced by PTC suppression with Ataluren, thus providing a greater therapeutic benefit [86]. This evidence concerns the gene CFTR and cystic fibrosis.